Discounted Cash Flow
Concentrix Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2019 | $4.7b | $117.2m | $338.6m | 2.5% | $2.27 |
| 2020 | $4.7b (0.2%) | $164.8m (40.7%) | $336.3m (-0.7%) | 3.5% (40.3%) | $3.19 (40.7%) |
| 2021 | $5.6b (18.4%) | $405.6m (146.1%) | $365.1m (8.6%) | 7.3% (107.9%) | $7.90 (147.3%) |
| 2022 | $6.3b (13.2%) | $435.0m (7.3%) | $460.7m (26.2%) | 6.9% (-5.2%) | $8.47 (7.3%) |
| 2023 | $7.1b (12.5%) | $313.8m (-27.9%) | $497.5m (8.0%) | 4.4% (-35.9%) | $5.83 (-31.1%) |
| 2024 | $9.6b (35.2%) | $251.2m (-20.0%) | $428.7m (-13.8%) | 2.6% (-40.8%) | $3.87 (-33.7%) |
| 2025 | $9.8b (2.2%) | $-1.3b (-609.1%) | $572.5m (33.5%) | -13.0% (-598.4%) | $-20.30 (-625.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.